Back to search

Article

The Impact of Polypharmacy Therapeutic classes on Mortality Outcomes in Patients with Chronic Liver Disease

2025-04-04

Abstract excerpt

Despite its pivotal role in drug metabolism, the exact consequences of rising medica-tions count from various therapeutic drug classes on mortality outcomes amongst patients with chronic liver disease remains unexplored. In this study, we investigated the effect of different polypharmacy phenotypes on clinical outcomes including the length of hospitalization, the need for intensive care admission, and mortality in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b8db91ea-563b-5d26-adba-2f9d9319609e
DOI
10.20944/preprints202504.0342.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Impact of Polypharmacy Therapeutic classes on Mortality Outcomes in Patients with Chronic Liver DiseaseDOI 10.20944/preprints202504.0342.v1
Prevalence and global trends of polypharmacy in patients with chronic Liver disease: a systematic review and meta-analysisSemantic proximity
Risk Factors for Tigecycline-Associated Drug-Induced Liver Injury in Critically Ill Patients: A 2020-2023 Retrospective Study from a Chinese HospitalSemantic proximity
Polypharmacy and potentially inappropriate medications in older adults who use long-term care services: A cross-sectional studySemantic proximity
Prevalence and Global Factors Influencing Polypharmacy and its Clinical Phenotypes in Cancer Patients: A Systematic Review and Meta-AnalysisSemantic proximity
Pharmacogenomic and drug interaction risk associations with hospital length of stay among Medicare Advantage members with COVID-19Semantic proximity
High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: A real-world retrospective study.Semantic proximity
Drug-induced liver injury in older people.Semantic proximity
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C StudySemantic proximity
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.Semantic proximity
Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categoriesSemantic proximity
Fecal microbiota transplantation in severe alcohol-associated hepatitis: mortality effect and 3 PM-guided analysis of associated factors.Semantic proximity
Assessment and Prediction of Clinical Outcomes for ICU-Admitted Patients Diagnosed with Hepatitis: Integrating Sociodemographic and Comorbidity DataSemantic proximity
Select a neighboring publication to make it the new centre.